论文部分内容阅读
直流电药物离子导入疗法有直流电电流与药物的复合作用,共临床应用价值已被各国学者所肯定。视网膜中央静脉阻塞常用尿激酶(Urokinase)治疗,多数采用静脉滴注或球后注射,国内外尚无用直流电将尿激酶导入眼内的治疗方法的报道。为了探讨尿激酶是否可以导入眼內及其在眼內各部位的分布和浓度,将尿激酶标记上同位素~3H,以示踪观察尿激酶导入眼内的情况,现报道如下: 实验方法一、试剂制备:采用丹东市鸭绿江制药厂生产的尿激酶10000单位,在实验前一天
DC drug iontophoresis therapy has a combination of DC current and drugs, the total clinical value has been affirmed by scholars in various countries. Central retinal vein occlusion commonly used urokinase (Urokinase) treatment, the majority of intravenous drip or ball injection, there is no direct use of DC at home and abroad to introduce urokinase in the treatment of the report. In order to investigate whether urokinase can be introduced into the eye and its distribution and concentration in various parts of the eye, the urokinase labeled isotope ~ 3H, to trace the situation of urokinase into the eye, are reported as follows: Experimental methods, Reagent preparation: Dandong Yalu Jiang Pharmaceutical Factory production of urokinase 10,000 units, the day before the experiment